144 related articles for article (PubMed ID: 100778)
1. [Treatment of bronchial lesions in pulmonary tuberculosis with primary drug resistance of Mycobacteria].
Fedotova ZN; Shesterina MV
Probl Tuberk; 1978 Aug; (8):31-4. PubMed ID: 100778
[No Abstract] [Full Text] [Related]
2. [Primary drug resistance of tuberculosis mycobacteria].
Fedotova ZN; Kerpel' RS
Probl Tuberk; 1971; 49(11):33-7. PubMed ID: 5004856
[No Abstract] [Full Text] [Related]
3. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
Fomicheva NI; Terentieva AS
Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
[No Abstract] [Full Text] [Related]
4. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
Nitti V
Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
[No Abstract] [Full Text] [Related]
5. [Changes and patterns of drug resistance of mycobacterium tuberculosis in patients with pulmonary tuberculosis (by data of the microbiological laboratory of research production association "Phthysiology")].
Gorokhova TV
Probl Tuberk; 1997; (2):33-5. PubMed ID: 9235582
[TBL] [Abstract][Full Text] [Related]
6. [Effect of aggravating factors on the effectiveness of the treatment of newly detected patients with destructive pulmonary tuberculosis].
Zozuliak VI
Vrach Delo; 1988 Jun; (6):54-5. PubMed ID: 3138824
[No Abstract] [Full Text] [Related]
7. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
[No Abstract] [Full Text] [Related]
8. [Bronchial involvement in tuberculosis in children].
Dubus JC
Rev Mal Respir; 1996 Dec; 13(6):609-10. PubMed ID: 9036510
[No Abstract] [Full Text] [Related]
9. Risk factors for drug resistance in pulmonary tuberculosis inpatients.
Yang X; Li Y; Wen X; Wu G; Li X
J Evid Based Med; 2010 Aug; 3(3):162-7. PubMed ID: 21349061
[TBL] [Abstract][Full Text] [Related]
10. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
[TBL] [Abstract][Full Text] [Related]
11. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
Saltini C; Velluti G; Mantovani P
Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
[No Abstract] [Full Text] [Related]
12. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
Ianovskaia OM; Poliakova AN; Samuliak ID; Vasilik GV
Probl Tuberk; 1975; (11):69-71. PubMed ID: 815904
[No Abstract] [Full Text] [Related]
13. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
Kochetov BI; Gur'ian IE
Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
[No Abstract] [Full Text] [Related]
14. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
Mamolat AS; Bialik IB; Khutorskaia VD
Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
[No Abstract] [Full Text] [Related]
15. [Frequency and clinical importance of primary pharmacoresistance of Mycobacteria in patients with tuberculosis of the lungs].
Bibik NF
Probl Tuberk; 1972; 50(8):20-5. PubMed ID: 4626690
[No Abstract] [Full Text] [Related]
16. Tuberculosis presenting as an endobronchial mass.
Kreisel D; Arora N; Weisenberg SA; Saqi A; Krupnick AS; Demetriades AM; Iakovou C; Conetta R; Lee PC
J Thorac Cardiovasc Surg; 2007 Feb; 133(2):582-4. PubMed ID: 17258612
[No Abstract] [Full Text] [Related]
17. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
Krasucka-Kluźniak A; Krakówka P
Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
[TBL] [Abstract][Full Text] [Related]
18. [Relations between resistance and virulence of mycobacteria].
Daddi G
Arch Monaldi; 1972; 27(4):426-35. PubMed ID: 4217599
[No Abstract] [Full Text] [Related]
19. [Preliminary results of rifabutine (ansamycine LM 427) treatment of patients with newly detected and chronic pulmonary tuberculosis and Mycobacterium infections].
Rowińska-Zakrzewska E; Słupek A; Graczyk J; Zwolska-Kwiek Z; Augustynowicz-Kopeć E; Stambrowska A; Byszewska D; Latoś E; Pilarska A; Andrzejczyk Z
Pneumonol Alergol Pol; 1992; 60(9-10):81-8. PubMed ID: 1338003
[No Abstract] [Full Text] [Related]
20. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
